|

Belimumab (GSK1550188) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BEL (BENLYSTA)

Pipeline

Phase 4: 1

Top Sponsors

  • GlaxoSmithKline1

Indications

  • Systemic Lupus Erythematosus1
  • Lupus1

Anniston, Alabama1 trial

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

GSK Investigational Site

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.